Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF

A generic image of a stock chart
Credit: Shutterstock photo

For Immediate Release

Chicago, IL - February 10, 2017 - Today, Zacks Equity Research discusses the Industry: Health Insurance, Part 1, including Anthem Inc. (NYSE: ANTM - Free Report ), Cigna Corp. (NYSE: CI - Free Report ), Aetna Inc. (NYSE: AET - Free Report ), Humana Inc. (NYSE: HUM - Free Report ) and U.S. Healthcare Providers iShares ETF (NYSEARCA: IHF - Free Report ).

Industry: Health Insurance, Part 1


The healthcare space as a whole has been in the eye of a storm over the past year, with the divergent policy platforms of the two presidential campaigns offering different paths for the sector going forward. Some of the industries in the broader healthcare space like pharmaceuticals have remained under a cloud even after the election, but the overall uncertain outlook for Obamacare and final regulatory shape of this space continues to be a headwind for the sector as a whole.

The health insurance industry, however, has done reasonably well despite these issues. The Zacks health maintenance organization (HMO) industry, part of the Zacks Medical sector, was up +7.7% since the start of 2016 through November 7 th . During that same time period, the Zacks Medical sector was down -13.1% (the S&P 500 index was up +4.1% in that time period). Since November 8 th , the industry is up +12.5% while the Zacks Medical sector is up only +4.7% (the S&P 500 index is up +8.1%).

The outperformance suggests that market participants don't see the emerging policy landscape to be unfavorable for the HMO industry. Market participants likely expect the underperforming public exchange business to get fixed and regulatory constraints on the two proposed mega mergers of Anthem Inc. (NYSE: ANTM - Free Report ) with Cigna Corp. (NYSE: CI - Free Report ) and that of Aetna Inc. (NYSE: AET - Free Report ) with Humana Inc. (NYSE: HUM - Free Report ) to get eased.

The industry witnessed a massive overhaul following the Health Care Reform Act which came into effect in Mar 2010. The reform changed the face of the industry, so much so that the once-successful strategies and business practices of the players were no longer sustainable.

The players enjoyed no interference from government entities from the early 1980s until 2010. The health insurers were fully autonomous in conducting their business, many times refusing to grant coverage to people with pre-existing diseases and rejecting genuine claims. But with the implementation of Obamacare, things changed substantially.

Did the Reform Really Affect Health Insurance Stocks?

The reform, along with its numerous provisions, put a number of restrictions on insurers. Some of the clauses of the law related to the provision of insurance coverage for people with preexisting diseases, a bar on rejecting claims, restrictions on increases in premium and many more have changed the operating environment of the industry. These players were now faced with increased competition, regulatory compliance costs, changing patient mix, pricing pressure, rising consumerism, higher taxes and fees, rising medical costs and a general marketplace uncertainty.

The sea change that occurred in the industry got the players on their toes to remodel their business with innovative, consumer-centric products and services. They have since then aggressively been hunting for new avenues of growth both at home and abroad.

The players, after initially protesting the law, eventually came to grips and realigned their businesses within the new mandates. This is evident from increasing profitability year after year since 2010 for almost all the players. This is also evident from the U.S. Healthcare Providers iShares ETF (NYSEARCA: IHF - Free Report ) 150% gain and the Zacks classified Medical - Health Maintenance Organization industry's growth of 175.32% since the passage of the reform in Mar 2010 versus 95.3% growth of the S&P 500.

Why Insurance Stocks Still Have Some Upside Left

While the industry outperformed the broader market over the last six years, valuations are far from nose-bleed expensive. The Zacks HMO industry is currently trading at 15.8X forward 12-month consensus EPS estimates. This isn't cheap, but it remains below the 10-year high forward 12-month P/E of 18X.

The industry is also trading favorably relative to the S&P 500 index, which is currently trading at a 10-year high forward P/E multiple of 17.9X.

Zacks Industry Rank

Within the Zacks Industry classification, health insurers are broadly grouped in the Medical sector (one of the 16 Zacks sectors).

We rank 265 industries into 16 Zacks sectors based on the earnings outlook and fundamental strength of the constituent companies in each industry. We put our X industries into two groups: the top half (industries with the best average Zacks Rank) and the bottom half (the industries with the worst average Zacks Rank).

Over the last 10 years, using a one-week rebalance, the top half beat the bottom half by more than twice as much. The Zacks Industry Rank is #177 (bottom 34%). The ranking is available on the Zacks Industry Rank page .

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on ANTM - FREE

Get the full Report on CI - FREE

Get the full Report on AET - FREE

Get the full Report on HUM - FREE

Get the full Report on IHF - FREE

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Anthem, Inc. (ANTM): Free Stock Analysis Report

Cigna Corporation (CI): Free Stock Analysis Report

Aetna Inc. (AET): Free Stock Analysis Report

Humana Inc. (HUM): Free Stock Analysis Report

ISHARS-US H C P (IHF): ETF Research Reports

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More